Pulmonary hypertension is a broad category of diseases characterized by shortness of breath, fatigue, and fluid buildup in the right side of the heart. A severe form of the condition known as pulmonary artery hypertension (PAH) can lead to early death. However, several new medications offer expanded treatment options and new hope for people with PAH.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.